Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Altamira Therapeutics Ltd (NQ: CYTO ) 0.6844 +0.0244 (+3.70%) Streaming Delayed Price Updated: 11:19 AM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Altamira Therapeutics Ltd < Previous 1 2 3 4 5 6 7 8 9 Next > Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray Today 9:01 EDT From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results September 24, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics to Host First Half 2024 Financial Results and Business Update Call on September 24, 2024 September 20, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Announces Closing of up to $12.0 Million Public Offering September 19, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Announces Pricing of up to $12.0 Million Public Offering September 17, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Announces Expansion of Bentrio License and Distribution Agreement with Nuance Pharma in East and South East Asia September 16, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference September 9-11 September 03, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Announces Extension of Bentrio Distribution Agreement with Pharma Nordic to Include Sweden and Denmark August 23, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Announces Confirmed Suitability of Bentrio for Athletes as Comprehensive Testing Shows Absence of Prohibited Substances August 16, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday August 15, 2024 Pre-market stock movers are worth checking out on Thursday morning as we dive into all of the hottest news today! Via InvestorPlace Why Lumentum Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket August 15, 2024 Via Benzinga Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in Combination with Zbtb46 mRNA Delivered with SemaPhore Nanoparticles in Animal Tumor Models August 12, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore Nanoparticles July 19, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management June 20, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Provides Business Update May 28, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Hunting For Gains In Penny Stocks May 26, 2024 On Thursday, I saw that some penny stocks were already trading over 100 million shares, with others around 30 million. It was clear: penny stocks were in focus. Here’s how the trades went down. Via Talk Markets Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032 May 24, 2024 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:RENB),(NASDAQ:CYTO),(NYSE:PFE),(NYSE:ABBV) EQNX::TICKER_END Via FinancialNewsMedia Topics Death Exposures Death 12 Health Care Stocks Moving In Thursday's Intraday Session May 23, 2024 Via Benzinga Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032 May 24, 2024 From FN Media Group LLC Via GlobeNewswire What's Going On With Altamira Therapeutics Stock? May 23, 2024 Altamira Therapeutics shares are trading higher Thursday after the company announced highlights from its NASAR clinical trial with Bentrio nasal spray were published in video format on the social media... Via Benzinga Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal May 23, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation May 01, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal April 24, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Pre-Market Session April 22, 2024 Via Benzinga Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results April 10, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Earnings Scheduled For April 10, 2024 April 10, 2024 Companies Reporting Before The Bell • Delta Air Lines (NYSE:DAL) is projected to report quarterly earnings at $0.35 per share on revenue of $12.55 billion. Via Benzinga Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024 April 04, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Nasdaq Turns Higher; Akanda Shares Plunge March 25, 2024 U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Monday. The Dow traded down 0.37% to 39,331.42 while the NASDAQ rose 0.06% to 16,439.38. The S&P 500 also... Via Benzinga Topics Stocks Exposures US Equities Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session March 25, 2024 Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session March 25, 2024 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.